Related Experiment Video
Updated: Jan 13, 2026

Stimulation of Cytoplasmic DNA Sensing Pathways In Vitro and In Vivo
Published on: September 18, 2014
Ubiquitination-directed cytosolic DNA degradation governs cGAS-STING-mediated immune response to DNA damage
1Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, P.R. China.
Abstract:
Activation of cGAS-STING signaling in cancer cells requires cytosolic DNA produced by intrinsic or treatment-induced DNA damage. However, clinical efforts to exploit this pathway to improve immunotherapy have yielded limited success, highlighting gaps in understanding the link between DNA damage and immunotherapy. Here, we identify ubiquitination-directed cytosolic DNA degradation as a critical determinant for cGAS-STING activation following DNA damage. Mechanistically, the cytosolic DNA exonuclease TREX1 is degraded by the E3 ubiquitin ligase SPOP but is reversely stabilized by the deubiquitinase USP7. Cancer-associated SPOP mutations or USP7 overexpression elevate TREX1 levels, promoting cytosolic DNA degradation and impairing cGAS-STING-mediated immune activation. Notably, elevated USP7 expression correlates with reduced tumor-infiltrating lymphocytes and accelerated disease progression in patients undergoing chemoradiotherapy. Furthermore, USP7 inhibitors reduce TREX1 levels and restore immune responses following radiation. These findings elucidate the mechanisms linking DNA damage to immune activation and highlight USP7 inhibitors as potential enhancers of radioimmunotherapy.
Insights
DNA damage triggers immune responses via cGAS-STING signaling, but cancer can block this. We found that USP7 regulates TREX1, controlling DNA breakdown and immune activation, offering new targets for cancer immunotherapy.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- cGAS-STING pathway activation in cancer relies on cytosolic DNA from DNA damage.
- Clinical applications of cGAS-STING pathway for immunotherapy have shown limited success.
- Understanding the link between DNA damage and immunotherapy is crucial.
Purpose of the Study:
- To investigate the role of ubiquitination in cytosolic DNA degradation and its impact on cGAS-STING activation.
- To elucidate the mechanism by which TREX1 levels are regulated and influence immune responses.
- To identify potential therapeutic targets for enhancing radioimmunotherapy.
Main Methods:
- Investigated the interplay between E3 ubiquitin ligase SPOP, deubiquitinase USP7, and cytosolic DNA exonuclease TREX1.
- Assessed the impact of SPOP mutations and USP7 overexpression on TREX1 levels and DNA degradation.
- Analyzed the correlation between USP7 expression, tumor-infiltrating lymphocytes, and disease progression in cancer patients.
- Evaluated the efficacy of USP7 inhibitors in restoring immune responses following radiation treatment.
Main Results:
- Ubiquitination-directed degradation of TREX1 is critical for cGAS-STING activation after DNA damage.
- SPOP mutations or USP7 overexpression lead to increased TREX1, promoting DNA degradation and suppressing immune activation.
- Elevated USP7 expression in patients correlates with fewer tumor-infiltrating lymphocytes and worse outcomes with chemoradiotherapy.
- USP7 inhibitors decrease TREX1 levels and enhance immune responses to radiation.
Conclusions:
- The study reveals a novel mechanism linking DNA damage, TREX1 regulation, and immune activation through ubiquitination.
- USP7 plays a key role in controlling cytosolic DNA levels and modulating anti-tumor immunity.
- USP7 inhibitors represent a promising strategy to improve the efficacy of radioimmunotherapy by restoring cGAS-STING pathway function.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Anaphase Promoting Complex
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Inhibition of Cdk Activity

